This is particularly true and relevant for CCM disease, given the emerging evidence that variants in other genes besides CCM1/KRIT1, CCM2 and CCM3 are implicated, causing clinically indistinguishable phenotypes, and the concomitant necessity to search for both SNVs and CNVs in several exons. This evidence concerns the gene CCM2 and cerebral cavernous malformation.